PRCC-TFE3 Renal Carcinomas
- 1 December 2002
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Surgical Pathology
- Vol. 26 (12), 1553-1566
- https://doi.org/10.1097/00000478-200212000-00003
Abstract
The reappraisal of genetically defined subsets of renal tumors can help to highlight the key pathologic features of specific neoplastic entities. We report the morphologic, immunophenotypic, ultrastructural, and molecular features of 11 renal carcinomas bearing a t(X;1)(p11.2;q21) and/or the resulting PRCC-TFE3 gene fusion. The male/female ratio was 4:7. Ten patients were in the age range of 9-29 years and one was 64 years old (mean 21.3 years, median 15 years). The predominant histologic pattern was nested, with islands of tumor cells compartmentalized by thin-walled capillary vasculature. Minor variations on this pattern yielded solid, acinar, alveolar, and tubular architecture. Papillary architecture was seen in nine cases, usually as a minor component. Neoplastic cells were typically characterized by irregularly shaped nuclei with vesicular chromatin and small nucleoli not visible with a 10x objective, and cytoplasm that ranged from clear to densely granular and eosinophilic. Mitoses were extremely rare; 5 were found in 900 high power fields examined from the 11 neoplasms. The most distinctive immunohistochemical feature of these neoplasms was moderate to intense nuclear labeling for TFE3 protein. These tumors were also consistently immunoreactive for the RCC antigen (10 of 11) and CD10 (9 of 9), whereas cytokeratin and epithelial membrane antigen were negative in four cases and were positive focally in the others. Ultrastructurally, all of the six neoplasms examined showed features consistent with conventional-type (clear cell) renal carcinoma, although two demonstrated distinctive intracisternal microtubules. Both tumors tested contained PRCC-TFE3 fusion transcripts. The differential diagnosis includes conventional-type papillary renal cell carcinoma, conventional-type (clear cell) renal carcinoma, and the ASPL-TFE3 renal carcinomas associated with the t(X;17)(p11.2;q25), with the latter two being morphologically the most similar to the t(X;1) renal carcinomas. Aside from their distinctive clinicopathologic features described here, there is experimental evidence suggesting that these tumors may show differential sensitivity to certain chemotherapeutic agents.This publication has 31 references indexed in Scilit:
- Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma: A Distinctive Tumor Entity Previously Included among Renal Cell Carcinomas of Children and AdolescentsThe American Journal of Pathology, 2001
- Use of Antibodies to RCC and CD10 in the Differential Diagnosis of Renal NeoplasmsThe American Journal of Surgical Pathology, 2000
- Translocation (X;1) Associated with a Nonpapillary Carcinoma in a Young Woman: A New Definition for an Xp11.2 RCC SubtypeCancer Genetics and Cytogenetics, 1999
- Skeletal and extraskeletal myxoid chondrosarcomaCancer, 1998
- CorrespondenceCancer Genetics and Cytogenetics, 1998
- Olfactory Neuroblastoma is Not Related to the Ewing Family of TumorsThe American Journal of Surgical Pathology, 1998
- Translocation (X;1) reveals metastasis 31 years after renal cell carcinomaCancer Genetics and Cytogenetics, 1998
- Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinomaOncogene, 1997
- Antigen Unmasking on Formalin-Fixed Paraffin-Embedded Tissues Using MicrowavesAdvances in Anatomic Pathology, 1995
- Cytogenetics of a renal adenocarcinoma in a 2-year-old childCancer Genetics and Cytogenetics, 1986